baber/WOPTO huggingface dataset:
Patent DE-60216261-T2 (DE)
Inventor: SEKOGUCHI YOSHINORI
IPC: A61L9/22
Filed: 2002-04-19
Granted: 2007-06-14
Abstract: A switching transformer applies an AC high voltage to the inner and outer electrodes opposed to each other and disposed on both sides of a dielectric glass tube. The anode of a diode is connected to the outer electrode to which no voltage is supplied, and the cathode is grounded. When a relay parallel connected to the diode is turned on, approximately the same amounts of positive and negative ions are generated. These ions are released into the air, thereby producing eradicating and sterilizing effects. When the relay is turned off, a relatively small amount of positive ions and a relatively large amount of negative ions are generated. When these ions are released into the air, a relaxation effect by the negative ions is produced.
Patent DE-60223508-T2 (DE)
Inventor: CORMIER YVON
IPC: A61K45/00
Filed: 2002-03-25
Granted: 2008-09-25
Abstract: Use of nicotine receptor agonists for treating inflammatory diseases, including a variety of pulmonary diseases. Such agonists have fewer side effects than other anti-inflammatory drugs, such as steroids. Moreover, these agonists can be used alone or in combination with other anti-inflammatory drugs to alleviate pulmonary diseases. For example, a method of treating pulmonary inflammation of an inflammatory disease selected from the group of asthma, interstitial pulmonary fibrosis (IPF), sarcoidosis, hypersensitivity pneumonitis (HP), and bronchiolitis obliterans with organizing pneumonitis (BOOP) in an animal in need thereof having said inflammation, including administering orally or by inhalation to said animal a nicotinic receptor agonist.
Patent DE-60310212-T2 (DE)
Inventor: TANO KRISTER
IPC: A61K9/00
Filed: 2003-03-06
Granted: 2007-10-11
Abstract: The present invention relates to the use of hydrogen peroxide producing enzyme for manufacturing of a medicament for treatment and/or prevention of otitis media (inflammation in the middle ear), preferably in children. This enzyme is preferably NADH oxidase. The medicament is intended to be administered with lactoperoxidase into the nasal cavity.
Patent DE-60315569-T2 (DE)
Inventor: LAMBERTINI VITO
IPC: B81B1/00
Filed: 2003-07-18
Granted: 2008-05-21
Abstract: A photopolymeric/ultraviolet (UV) mixture particle layer (M) is exposed to UV radiations (F1,F2) and subjected to magnetic/electric field to produce desired orientation or positioning of the nanoparticles in order to induce the growth of surface projections (R) from the layer. The photopolymeric/ultraviolet mixture particle layer is selectively exposed to UV radiation in the areas in which the surface projections are formed, using a binary mask or half-tone mask. The photopolymeric/ultraviolet mixture particle layer is polymerized by exposing to UV radiation in the absence of application of magnetic/electric field. Independent claims are also included for the following: (1) a solid component having three-dimensional surface structures of nanometric/micrometric dimensions. The solid component has projections R having a height upto 500 microns arranged according to definite geometries; and (2) an apparatus for forming a three-dimensional structure having nanometric/micrometric dimensions.
Patent DE-68918860-T2 (DE)
Inventor: PANDEY RAVINDRA
IPC: A61K41/00
Filed: 1989-07-19
Granted: 1995-02-16
Abstract: Pyropheophorbide compounds are injected into a host and accumulate in tumor tissue to a higher degree than surrounding normal tissues. When the pyropheophorbide compounds are exposed to a particular wavelength of light the compounds become cytotoxic and destroy the tumor or diseased tissue without causing irreversible normal tissue damage. The pyropheophorbide compounds have shown improved results as compared to drugs currently used in photodynamic therapy. Further, they absorb light further in the red, optimizing tissue penetration and are retained in the skin for short time periods relative to other drugs used in photodynamic therapy.
Patent DE-68918959-T2 (DE)
Inventor: GRANT MICHAEL A
IPC: H04B7/195
Filed: 1989-01-18
Granted: 1995-03-02
Abstract: A multiple access communications system comprises a node spacecraft GEO and several user spacecraft LEO1 tO LEOn. Each user spacecraft LEO1 to LEOn includes a transmit/receive terminal head 181 to 18n, and the node spacecraft GEO includes n transmit/terminals 22 to 22n and a single beacon unit 24. The beacon beam may be operated to initiate acquisition phases which allow two-way communication to be established between the transmit/receive terminals 221 to 22n on the node spacecraft and the transmit/receive terminals 181 to 18n on the corresponding user terminals. The acquisition phases include a period during which the beacon scans an uncertainty cone associated with the node spacecraft. This scanning period is reduced for second and subsequent acquisitions by using the first and subsequently acquired communication links to provide a more accurate estimate of the angular attitude of the node spacecraft, thus reducing the extent of the uncertainty cone.
Patent DE-68925716-T2 (DE)
Inventor: TSIEN ROGER YONCHIEN
IPC: C07D413/14
Filed: 1989-11-14
Granted: 1996-06-13
Abstract: The invention discloses fluorescent chelator compounds that are especially useful to monitor and measure cytosolic concentrations of alkali metal cations such as Na<+>, K<+>, and Li<+>. The new compounds are comprised of: (1) crown ethers (that may or may not have substituent groups attached to the core carbons, but will always contain at least one core nitrogen) that are linked via the core nitrogen(s) to at least one (2) fluorophore that contains an additional heteroaromatic liganding center. In the currently preferred dye, SBFI, the core compound is crown ether 1,7-diaza-4,10,13-trioxacyclopentadecane and the heteroaromatic fluorophores are benzofurans that are linked to isophthalate groups. Selectivities for Na<+> over K<+> of about 20 are observed, resulting in effective dissociation constants for Na<+> of about 20 mM against a background of 120 mM K<+>. Increasing [Na<+>] increases the ratio of excitation efficiency at 330-345 nm to that at 370-390 nm with emission collected at 450-550 nm, so that ratio fluorometry and imaging work at the same wavelengths as used with the well-known Ca<2><+> indicator fura-2. If the macrocyclic ring is increased in size to a 1,10-diaza-4,7,13,16-tetraoxacyclooctadecane, the chelators become selective for K<+> over Na<+>. If the ring is decreased in size, for example to a 1,7-diaza-4,10-dioxacyclododecane, the chelators become selective for Li<+> over Na<+>.
Patent DE-68927188-T2 (DE)
Inventor: BEVILACQUA MICHAEL
IPC: A61K39/395
Filed: 1989-11-14
Granted: 1997-04-24
Abstract: The invention relates to a method for detecting ELAM-1 expression in a patient comprising (i) administration of a detectable amount of a labelled ELAM-1 specific antibody (or an anti-ELAM 1 antibody fragment) and a pharmaceutically acceptable carrier, and (ii) detecting the label. ELAM-1 is an endothelial cell surface glycoprotein which participates in endothelialleukocyte adhesion. Induction of ELAM-1 expression has been detected on endothelial cells at sites of inflammation.
Patent DE-69007544-T2 (DE)
Inventor: CRIQUILION JEAN
IPC: C08L27/06
Filed: 1990-05-22
Granted: 1994-09-29
Abstract: The compositions contain di-trimethylolpropane as a viscosity reducer in a proportion of 6 to 9 parts by weight per 100 parts of polyvinyl chloride. They advantageously contain a lead compound as primary heat stabilizer and a neutral lead carboxylate derived from C8-C30 fatty acids as lubricant. The compositions are particularly suitable for the manufacture of rigid articles such as housings for office processing equipment and for radio and television sets and gratings for cooling towers, by injection moulding.
Patent DE-69010921-T2 (DE)
Inventor: BATT DOUGLAS GUY
IPC: A61K31/44
Filed: 1990-01-03
Granted: 1995-03-09
Abstract: Provided are substituted indoles, benzofurans, and benzothiophenes of the formula <CHEM>  wherein X, R<2> and R<3> are described in the specification. These compounds are 5-lipoxygenase inhibitors and are useful as antiinflammatory agents.
Patent DE-69011943-T2 (DE)
Inventor: OKUIE TAKAYUKI
IPC: B41J2/015
Filed: 1990-03-28
Granted: 1995-05-04
Abstract: According to a method of controlling a head in an image recording apparatus, a valve body (16) made of a diaphragm is brought into tight contact with a valve seat (15) having a nozzle hole. A pressurized ink is supplied to a contact portion between the valve body (16) and the valve seat (15). A gap formed between the valve body (16) and the valve seat (15) upon supply of the pressurized ink is controlled by an actuator (21). The pressurized ink is discharged from the nozzle hole through the gap controlled by the actuator (21).
Patent DE-69021492-T2 (DE)
Inventor: BAKKER ANKE GEZINA
IPC: A61Q13/00
Filed: 1990-10-11
Granted: 1996-01-25
Abstract: The invention provides novel unsaturated monoaldehydes of general formula  R<1>-CH2-CH(R<2>)-(CH2)n-CH=C(CH3)2 wherein one of groups R<1> and R<2> represents a formyl group and the other represents a hydrogen atom and n is an integer from 2 to 8, preferably from 3 to 6, which compounds may be used as fragrants. The invention further relates to a hydroformylation process for the preparation of the novel unsaturated aldehydes.
Patent DE-69021881-T2 (DE)
Inventor: CLARK ALAN
IPC: H04Q11/04
Filed: 1990-06-15
Granted: 1996-01-11
Abstract: A data switching node comprises a plurality of data lines including high speed data (link) lines and low speed data (port) lines and a switch connected to the data lines. The switch is a distributed multiplexer comprising a number of switching modules (A1-Am, P1-Pn) connected in common to a data bus (1). The switching modules (A1-Am, P1-Pn) are arranged to communicate data with the common data bus (1). A control module (2) is also connected to the bus (1) and arranged to control the addressing of the switching modules so that data received by a switching module connected to one data line is transmitted directly via the common data bus (1) to a switching module connected to a selected other one of the data lines in response to a control signal from the control module identifying the said switching module, the data being transmitted in association with a logical channel number associated with the switching module connected to the selected other one of the data lines. In a method of operating a multiplexer particularly suitable for use with the data switching node a plurality of channels are received and transmitted as byte-interleaved frames. Each incoming channel is assigned a logical channel number and written to a byte or bit position of the outgoing data frame selected in accordance with the logical channel number. The outgoing frame is assembled and output substantially coincidentally with the incoming data frame.
Patent DE-69023894-T2 (DE)
Inventor: RODRIGUEZ PETER A
IPC: D21F1/48
Filed: 1990-07-23
Granted: 1996-07-04
Abstract: An improved system in a paper making process of forming and dewatering fiber/aqueous dispersion (44) by submerged drainage in which air does not penetrate the fiber/aqueous dispersion (44) nor the paper web as it is being formed; the dewatering being accomplished by altering the natural tension of the water meniscus so as to induce enhanced drainage of water from the aqueous dispersion (44) of paper making fibers, especially in the wetter end of the system.
Patent DE-69026963-T2 (DE)
Inventor: AGRAWAL SUDHIR
IPC: C07H21/00
Filed: 1990-04-05
Granted: 1996-11-07
Abstract: A process of producing synthetic oligonucleotides on a small or large scale using H-phosphonate nucleoside monomers is described. The process can be used to synthesize oligonucleotides of any length, including oligodeoxyribonucleotides and oligoribonucleotides. The process results in a coupling efficiency of greater than 97% and consumes only two to three equivalents of monomer to activator per coupling reaction. In addition, the process does not require a separate capping step and capping reagent because the activating reagent serves a self-capping function thereby preventing elongation of failed sequences. The H-phosphonate linkages of the fully synthesized oligonucleotide can be oxidized with a variety of reagents to obtain either phosphate diester or other types of modified oligonucleotides.
Patent DE-69101010-T2 (DE)
Inventor: CURCIO MARIA
IPC: A61F2/24
Filed: 1991-02-20
Granted: 1994-05-05
Abstract: The suture ring (3) has a core (4) for form-coupling with the stent (2) of the prosthesis so that the suture ring (3) and the stent (2) are held securely together axially, whilst the core (4) can rotate relative to the stent. The suture ring (3) has a covering (5) which cooperates with the surface of the stent (2) and is in contact therewith. The degree of contact determines the resistance to relative rotation of the ring (3) and the stent (2). <IMAGE>
Patent DE-69107375-T2 (DE)
Inventor: HUTCHINSON BEN MAXWELL
IPC: B23D63/12
Filed: 1991-08-22
Granted: 1995-10-05
Abstract: A sharpening apparatus (10) is disclosed. The apparatus (10) has a pivot arm (18) for pivotal movement about shaft (21) extending transversely of the apparatus. The location of shaft (21) is variable to suit a variety of hook angles of the blade (33) <IMAGE>
Patent DE-69111880-T2 (DE)
Inventor: STANLEY SAMUEL LEONARD
IPC: G01N33/53
Filed: 1991-04-29
Granted: 1996-02-22
Abstract: An Entamoeba histolytica specific cDNA clone which encodes an antigenic surface membrane protein possessing multiple tandem repeats and expression in E. coli is disclosed.
Patent DE-69120399-T2 (DE)
Inventor: GO JUNICHI
IPC: E04H6/22
Filed: 1991-12-04
Granted: 1997-02-06
Abstract: A multistory parking system (1) comprises: a plurality of motor vehicle housing chambers (X1, Y1, etc.) arranged in the vertical direction; a lifting space (31) provided, adjoining the motor vehicle chambers; a lift (4) vertically movable along the lifting space (31) with a motor vehicle mounted thereon; and a motor vehicle conveying truck (7) capable of receiving and delivering the motor vehicle between this lift (4) and itself. The motor vehicle conveying truck (7) includes: driving wheels (9); a driving motor (25) for driving these driving wheels (9); and a battery device (19). The battery device (19) supplies the power accumulated therein to the driving motor (25) during driving of the truck (7). Therefore, the motor vehicle conveying truck (7) can move between the motor vehicle housing chambers (X1, Y1, etc.) and the lifting space (31) on its own power. <IMAGE>
Patent DE-69126569-T2 (DE)
Inventor: BERETTA GIOVANNI
IPC: F16D43/26
Filed: 1991-07-05
Granted: 1997-11-13
Abstract: Actuation device for the programming of rotary dobbies for actuating frame heddles in looms, comprising a selection lever (19, 119) rotatable about a fixed pivot (19a, 119a) under the action exerted by pressure beams (27, 28) acting on thrust means (21, 22) articulated to one end of said lever (19, 119) for the purpose of positioning projections (19b, 19c, 119b, 119c) of the selection lever (19, 119) along - or outside - the path followed by the outer end of the lever (9, 10, 110) during one half-revolution, for the purpose of determining - or otherwise - the variation in the position of the frame, said rotation of said lever (19, 119) being effected during the rotation of the shaft (1) and being held by positioning (24, 25, 29, 30) and blocking (31, 32, 34, 134) means associated with said thrust means (21, 22). <IMAGE>
Patent DE-69128249-T2 (DE)
Inventor: GLENN STEPHAN
IPC: A61K9/08
Filed: 1991-06-20
Granted: 1998-06-25
Abstract: A single filtration device containing coated filter membranes and absolute pore filters is provided in which the membranes and absolute pore filters are present in two sections of the filter device. The filter device will remove viruses, as modeled by type-C Xenotropic retrovirus, with an efficiency of at least 4.6x105; remove DNA from levels of 10  mu g/sample to levels below 10 picograms per 500 mg sample of monoclonal antibody; and will remove at least 97% of some bacterial endotoxins.
Patent DE-69206318-T2 (DE)
Inventor: VIGNAUD JEAN-LOUIS
IPC: A61B17/58
Filed: 1992-05-14
Granted: 1996-07-18
Abstract: - The invention relates to a lockable connection device for two spinal osteosynthesis anchoring elements (3), the said anchoring elements (3) comprising an osseous fastening part (4) formed by a screw, by a curved plate or the like and a body for fastening a solid-attachment rod formed by a tuning-fork-shaped head (5) receiving the said rod as well as an immobilising screw (6), characterised in that it consists of two annular elements (9) each capable of being externally fitted onto one of the tuning-fork-shaped heads (5), each annular element (9) comprising an external immobilisation rod (10) which can slide in a clamping collar (11), the two clamping collars (11) of the device being clamped by a common screw (12) passing through the said collars. - Application in particular to spinal osteosynthesis. <IMAGE>
Patent DE-69208797-T2 (DE)
Inventor: CAMPBELL COLIN D DR
IPC: C07C69/757
Filed: 1992-09-22
Granted: 1996-09-19
Abstract: A process for the preparation of dialkyl succinylsuccinate esters from mixtures of dialkyl succinates, formed by separate or in situ transesterification of dimethyl succinate with C<6> to C1/4  alkanols and their conversion to dialkyl 2,5-diarylamino-3,6-dihydroterephthalate esters having high solubility in organic solvents.
Patent DE-69224486-T2 (DE)
Inventor: CLEMENT KATHERINE
IPC: C07D311/82
Filed: 1992-10-20
Granted: 1998-06-04
Abstract: Active methine compounds are chlorinated by contacting such compounds with a perchloroalkane and aqueous base in the presence of a phase transfer catalyst which is an tetraalkylonium hydroxide. Chlorinated products, preferably tertiary alkyl chloro compounds, are produced. The tertiary alkyl chloro compounds are useful in elimination reactions, preferably reactions with base, to form unsaturated compounds, particularly compounds having a vinylidene or exomethylene group.
Patent DE-69225960-T2 (DE)
Inventor: GIBADLO MARY
IPC: C12N5/10
Filed: 1992-01-30
Granted: 1999-01-21
Abstract: Monoclonal antibodies which specifically bind to putative Hepatitis C Virus (HCV) envelope region. Also provided are hybridoma cell lines which secrete these monoclonal antibodies, methods for using these monoclonal antibodies, and assay kits which contain these monoclonal antibodies.
Patent DE-69226775-T2 (DE)
Inventor: PHILIPP WOLFGANG
IPC: C12Q1/70
Filed: 1992-06-25
Granted: 1999-01-14
Abstract: PCT No. PCT/FR92/00586 Sec. 371 Date Feb. 10, 1994 Sec. 102(e) Date Feb. 10, 1994 PCT Filed Jun. 25, 1992 PCT Pub. No. WO93/00435 PCT Pub. Date Jan. 7, 1993DNA sequences derived from human papillomavirus HPV42 are disclosed. Also disclosed are methods of using these sequences as hybridization probes in diagnostic assays.
Patent DE-69229342-T2 (DE)
Inventor: UNGER EVAN C
IPC: A61B6/03
Filed: 1992-03-18
Granted: 1999-10-14
Abstract: The invention provides contrast media for diagnostic imaging comprising a substantially homogeneous aqueous suspension of gas-filled microspheres, wherein the microspheres are filled with a perfluorocarbon gas. The microspheres are preferably formed from biocompatible synthetic polymers or copolymers.
Patent DE-69310231-T2 (DE)
Inventor: DOMENICALI PETER L
IPC: H01L21/027
Filed: 1993-02-05
Granted: 1997-08-28
Abstract: A proximity mask alignment system (1) includes a remotely-focusing microscope (14) and a video frame storage device (34c). When a first surface, such as an integrated circuit substrate (12), is in focus an image of the first surface is obtained and stored. Then, after the microscope is re-focused to a second surface, such as a photomask (10), the stored image of the first surface is superimposed onto the "live" image of the second surface. The two focal positions are stored, with a selected one being normally provided to the microscope. A user initiates an automatic sequence wherein the microscope focuses to the other focal position, stores an image obtained at the other focal position, then refocuses to the original focal position. The stored image is superimposed on the image currently being generated, enabling the user to simultaneous view each surface in sharp focus, facilitating the alignment of the two surfaces to one another. <IMAGE>
Patent DE-69322239-T2 (DE)
Inventor: MEADE THOMAS E
IPC: A61F5/56
Filed: 1993-05-26
Granted: 1999-05-06
Abstract: An apparatus for intra-oral use including a framework having a upper curved platform (12) and a lower curved platform (14), each of the platforms being defined by two walls extending from and separated by a floor, a material bonded to the upper and lower curved platform adapted to be molded in a shape suitable for relatively snugly receiving maxillary teeth (100) of a user and for relatively loosely receiving mandibular teeth (102) of the user when the user's mouth is closed in a normal closing arch, and a cavity (32) formed between the upper and lower platforms adapted to receive the tongue of the user. <IMAGE>
Patent DE-69324212-T2 (DE)
Inventor: SHUTSKE GREGORY
IPC: A61P29/00
Filed: 1993-11-22
Granted: 1999-09-16
Abstract: This invention relates to indole-7-carboxamide derivatives of the formula <CHEM> where R1 through R6 are independently H, loweralkyl, and aralkyl; and in addition R3 and R5 can be joined together to form a piperazine ring of the formula <CHEM> where R7 is H, loweralkyl, aryl, arylloweralkyl, pyrimidyl; and R4 and R5 can be joined together to form a pyrrolidine ring of the formula <CHEM> where R8 is H, loweralkyl, arylloweralkyl; X is H, loweralkyl, halogen, NO2, CF3, NH2, and OR9; where R9 is loweralkyl, arylloweralkyl and n is an integer of 1 to 3; and the pharmaceutically acceptable acid addition salts thereof and the optical isomers thereof where such isomers exist.
Patent DE-69326162-T2 (DE)
Inventor: BUDZILEK RUSSELL
IPC: H05B33/12
Filed: 1993-12-09
Granted: 2000-04-27
Abstract: An AC thin film electroluminescent display panel includes a metal assist structure formed on and in electrical contact over each transparent electrode, and light absorbing darkened rear electrodes which combine to provide a sunlight viewable display panel.
Patent DE-69330204-T2 (DE)
Inventor: HUBBARD WILLIAM G
IPC: A61L27/46
Filed: 1993-02-05
Granted: 2001-11-08
Abstract: A permanent, biocompatible material for soft tissue augmentation. The biocompatible material comprises a matrix of smooth, round, finely divided, substantially spherical particles of a biocompatible ceramic material, close to or in contact with each other, which provide a scaffold or lattice for autogenous, three dimensional, randomly oriented, non-scar soft tissue growth at the augmentation site. The augmentation material can be homogeneously suspended in a biocompatible, resorbable lubricious gel carrier comprising a polysaccharide. This serves to improve the delivery of the augmentation material by injection to the tissue site where augmentation is desired. The augmentation material is especially suitable for urethral sphincter augmentation, for treatment of incontinence, for filling soft tissue voids, for creating soft tissue blebs, for the treatment of unilateral vocal cord paralysis, and for mammary implants. It can be injected intradermally, subcutaneously or can be implanted.